LeonaBio (LONA) Asset Writedowns and Impairment (2020)

LeonaBio's (LONA) quarterly Asset Writedowns and Impairment came in at -$2000.0 in Q4 2020, down 100.18% on a QoQ basis from $1.1 million in Q3 2020.

LeonaBio (LONA) Asset Writedowns and Impairment (2020) Analysis & Trends

LeonaBio (LONA) has 1 years of Asset Writedowns and Impairment data on file, last reported at -$2000.0 in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	66,621.14 Bn	66,620.85 Bn	-
2	Nanobiotix	1,915.18 Bn	1,915.11 Bn	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-
4	BeOne Medicines	471.27 Bn	466.48 Bn	1.35 Bn
5	Vertex Pharmaceuticals	121.81 Bn	114.57 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	69.58 Bn	60.82 Bn	3.31 Bn
7	Belite Bio	62.72 Bn	62.72 Bn	-
8	Argenx Se	55.51 Bn	50.33 Bn	1.41 Bn
9	Revolution Medicines	37.35 Bn	37.35 Bn	-
10	LeonaBio	138.33 Mn	70.65 Mn	-

Download Data